March 16, 2026 · Form 4 insider transaction
Farnum Rhonda sold 15,534 shares of Theravance Biopharma, Inc. at $14.00 per share, a transaction worth $217.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.